Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GW Pharmaceuticals PLC

www.gwpharm.com

Latest From GW Pharmaceuticals PLC

GW Pharmaceuticals Scores EU First For Cannabinoid Drug

GW Pharmaceuticals is pressing on with plans to launch its epilepsy treatment Epidyolex in the EU, starting with France and Germany.

Europe Approvals

Pent-Up Demand As GW Pharma’s Epidyolex Approved In Europe

Drug will meet pent-up demand in Europe for clinically proven cannabis-based medicine for hard-to-treat epilepsy.

Europe Approvals

New EU Approvals

The Pink Sheet’s list of EU centralized approvals of new active substances now includes three new products including GW Pharmaceuticals' Epidyolex (cannabidiol) for treating patients with epilepsy. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

Europe Approvals

Bayer's Vitrakvi On Track To Become EU’s First Tumor-Agnostic Cancer Treatment

Five new medicines, including what could become Europe’s first ever tumor-agnostic cancer treatment, have been recommended for approval by the European Medicines Agency.
Europe Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • GW Pharmaceuticals PLC
  • Senior Management
  • Justin Gover, CEO
    Scott Giacobello, CFO
    Chris Tovey, COO
    Volker Knappertz , MD, CMO
  • Contact Info
  • GW Pharmaceuticals PLC
    Phone: (44) 1223 266800
    Sovereign House
    Vision Park
    Histon, Cambridge, CB24 9BZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register